Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies

BACKGROUND: Many clinical trials supporting new drug applications underrepresent minority patients. Trials conducted by the National Cancer Institute’s National Clinical Trial’s Network (NCTN) have greater outreach to community sites, potentially allowing better representation. We compared the repre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JNCI Cancer Spectr
Main Authors: Unger, Joseph M, Hershman, Dawn L, Osarogiagbon, Raymond U, Gothwal, Anirudh, Anand, Seerat, Dasari, Arvind, Overman, Michael, Loree, Jonathan M, Raghav, Kanwal
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7368466/
https://ncbi.nlm.nih.gov/pubmed/32704619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados